Antagonists of growth hormone-releasing hormone (GH-RH) inhibit in vivo proliferation of experimental pancreatic cancers and decrease IGF-II levels in tumours.
about
Expression of a splice variant of the receptor for GHRH in 3T3 fibroblasts activates cell proliferation responses to GHRH analogsIsolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers.Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone.Effective treatment of experimental human non-Hodgkin's lymphomas with antagonists of growth hormone-releasing hormoneAntagonists of growth hormone-releasing hormone cross the blood-brain barrier: a potential applicability to treatment of brain tumors.Antiproliferative effect of growth hormone-releasing hormone (GHRH) antagonist on ovarian cancer cells through the EGFR-Akt pathway.The expression of growth hormone-releasing hormone (GHRH) and splice variants of its receptor in human gastroenteropancreatic carcinomas.The expression of the pituitary growth hormone-releasing hormone receptor and its splice variants in normal and neoplastic human tissuesGrowth hormone-releasing hormone and extra-pituitary tumorigenesis: therapeutic and diagnostic applications of growth hormone-releasing hormone antagonists.Potentiation of mammary cancer inhibition by combination of antagonists of growth hormone-releasing hormone with docetaxel.New therapies for relapsed castration-resistant prostate cancer based on peptide analogs of hypothalamic hormones.Development of a polyclonal antiserum for the detection of the isoforms of the receptors for human growth hormone-releasing hormone on tumors.Antagonists of growth hormone-releasing hormone arrest the growth of MDA-MB-468 estrogen-independent human breast cancers in nude mice.The use of peptide analogs for the treatment of gastrointestinal, pancreatic, liver and urinary bladder cancers.Growth hormone receptor inhibition decreases the growth and metastasis of pancreatic ductal adenocarcinoma.Expression of growth hormone-releasing hormone receptor splicing variants in human primary adrenocortical tumours.Anti-proliferative and pro-apoptotic effects of GHRH antagonists in prostate cancer.Prognosis in human glioblastoma based on expression of ligand growth hormone-releasing hormone, pituitary-type growth hormone-releasing hormone receptor, its splicing variant receptors, EGF receptor and PTEN genes.Molecular challenges of neuroendocrine tumors.
P2860
Q24292089-2C52653A-92C5-4C34-B67D-BCDAEAE37A00Q24652328-AA78FCA7-0C12-47EC-891E-220DDF050AB8Q30454262-9BE4F7D6-D5E9-4096-B201-FD90965788B1Q33906715-3C92F8C9-66B1-4E2A-A58A-36BF53A5787DQ33933907-5778E4F5-A950-4842-BB62-5CF8A887D1ADQ33939652-4E4CA789-711C-49DC-AA3A-BBB9AE59D1C6Q34154583-F8F329F2-B166-4414-9DCE-1E30A3A4D938Q34161110-ADBC4609-01A2-4889-A3DA-77F9E6F6BA2BQ35185769-7620EB91-C74D-4706-AB8F-C8672C7FD57FQ35629436-0BA8FF12-B8AD-4D09-99BB-D797B1B10396Q36748502-A2A51C18-C445-4AC5-B3B8-D31F0988EAAFQ37589369-142A4A91-F837-4F38-94B4-BFA9EB2BF07CQ38311441-83E00388-2262-40EC-8511-E3BFC31BF4B8Q38472348-138F86A0-9749-43C5-8412-BD17CCEA2585Q38949257-3549244F-AA11-4121-AF08-C55279D33E49Q40430581-C2446DD5-F23C-4B7D-99CC-288FDE4B6997Q42330184-90F4C772-93DA-4C7F-837D-17BADF8AF280Q48749343-42C14A2B-BFA0-478D-A16E-82EDA29CF7F4Q49875027-0FAE9B30-815D-487D-8CD5-485D345570E1
P2860
Antagonists of growth hormone-releasing hormone (GH-RH) inhibit in vivo proliferation of experimental pancreatic cancers and decrease IGF-II levels in tumours.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Antagonists of growth hormone- ...... ease IGF-II levels in tumours.
@en
type
label
Antagonists of growth hormone- ...... ease IGF-II levels in tumours.
@en
prefLabel
Antagonists of growth hormone- ...... ease IGF-II levels in tumours.
@en
P2093
P1476
Antagonists of growth hormone- ...... ease IGF-II levels in tumours.
@en
P2093
P304
P356
10.1016/S0959-8049(99)00230-0
P577
2000-01-01T00:00:00Z